A transformative study has uncovered the pivotal role of the protein Naked cuticle homolog 2 (NKD2) in regulating the differentiation of bone-forming osteoblasts and bone-resorbing osteoclasts.

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

A transformative study has uncovered the pivotal role of the protein Naked cuticle homolog 2 (NKD2) in regulating the differentiation of bone-forming ...

With clinical trials results trickling in, “antiaging” drugs that clear away senescent cells are proving to be promising — and confounding.

Scientists resolved the ... Novel Bone Marrow Transplant Can Cure Sickle Cell Disease, Study Suggests Feb. 25, 2025 — A bone marrow transplant process is safe and curative for adults with sickle ...

Xintela's interim analysis of data from the knee osteoarthritis clinical study shows safety and positive efficacy results, 18 months after treatment with XSTEM. The results demonstrate statistically s ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he ...

The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.

Researchers develop method to precisely control calcium phosphate structure at the 300-nanometer scale using bone-forming ...

A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...

India's gene therapy for blood cancers shows 73% response rate, offering hope and cost-effective treatment for patients.